On December 28 the DCGI approved COVOVAX for restricted use in emergency situations in adults in the 12 to 17 years of age group. The director of Government and Regulatory Affairs at Serum Institute of India (SII) applied to DCGI on March 16. India launched a vaccination drive for people more than 45 years of age on April 1.
Bharat Biotech's Covaxin vaccine is developed using whole-virion inactivated Vero cell-derived platform technology. Read on to know the common side effects.
As per the recent guidelines by the government, children belonging to the particular age group will be jabbed with Corbevax, manufactured by Biological E. Limited.
Bharat Biotech's Covaxin vaccine is developed using whole-virion inactivated Vero cell-derived platform technology. Read on to know the common side effects.
As per the recent guidelines by the government, children belonging to the particular age group will be jabbed with Corbevax, manufactured by Biological E. Limited.
On December 28 the DCGI approved COVOVAX for restricted use in emergency situations in adults in the 12 to 17 years of age group. The director of Government and Regulatory Affairs at Serum Institute of India (SII) applied to DCGI on March 16. India launched a vaccination drive for people more than 45 years of age on April 1.
Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Refresh Page